What Researchers Did
Researchers investigated the molecular mechanism, specifically the role of Nrf2 and angiogenic markers, during hyperbaric oxygen (HBO) therapy for diabetic foot ulcers (DFU) in a randomized controlled trial.
What They Found
In 32 patients, HBO therapy significantly increased tissue levels of Nrf2 and its downstream targets compared to standard care (n=15 vs n=17). HBO therapy also induced angiogenesis, evidenced by increased levels of angiogenic markers like EGF, VEGF, PDGF, FGF-2, and CXCL10, along with elevated eNOS and nitrite concentrations.
What This Means for Canadian Patients
For Canadian patients with diabetic foot ulcers, these findings suggest that hyperbaric oxygen therapy could enhance wound healing by activating specific molecular pathways and promoting new blood vessel formation. This may lead to improved outcomes and faster recovery from these challenging wounds.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this study is its relatively small sample size of 32 patients, which may limit the generalizability of the findings.